IL155728A0 - Tolerizing allografts of pluripotent stem cells - Google Patents

Tolerizing allografts of pluripotent stem cells

Info

Publication number
IL155728A0
IL155728A0 IL15572801A IL15572801A IL155728A0 IL 155728 A0 IL155728 A0 IL 155728A0 IL 15572801 A IL15572801 A IL 15572801A IL 15572801 A IL15572801 A IL 15572801A IL 155728 A0 IL155728 A0 IL 155728A0
Authority
IL
Israel
Prior art keywords
tolerizing
allografts
stem cells
pluripotent stem
pluripotent
Prior art date
Application number
IL15572801A
Other languages
English (en)
Original Assignee
Geron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geron Corp filed Critical Geron Corp
Publication of IL155728A0 publication Critical patent/IL155728A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15572801A 2000-11-22 2001-11-21 Tolerizing allografts of pluripotent stem cells IL155728A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25268800P 2000-11-22 2000-11-22
PCT/US2001/043434 WO2002044343A2 (en) 2000-11-22 2001-11-21 Tolerizing allografts of pluripotent stem cells

Publications (1)

Publication Number Publication Date
IL155728A0 true IL155728A0 (en) 2003-11-23

Family

ID=22957090

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15572801A IL155728A0 (en) 2000-11-22 2001-11-21 Tolerizing allografts of pluripotent stem cells

Country Status (10)

Country Link
US (2) US20020086005A1 (zh)
EP (2) EP1757681A1 (zh)
JP (1) JP2004521877A (zh)
KR (1) KR20040029311A (zh)
CN (1) CN1863906A (zh)
AU (3) AU3929402A (zh)
CA (1) CA2427996A1 (zh)
GB (1) GB2386125B (zh)
IL (1) IL155728A0 (zh)
WO (1) WO2002044343A2 (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US7799324B2 (en) 2001-12-07 2010-09-21 Geron Corporation Using undifferentiated embryonic stem cells to control the immune system
CN1630716A (zh) 2001-12-07 2005-06-22 杰龙公司 人胚胎干细胞衍生的造血细胞
US7700090B2 (en) 2002-02-13 2010-04-20 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
US7285415B2 (en) 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US20040171147A1 (en) 2002-11-26 2004-09-02 Hariri Robert J. Cytotherapeutics, cytotherapeutic units and methods for treatments using them
NZ542127A (en) * 2003-02-13 2008-04-30 Anthrogenesis Corp Use of umbilical cord blood to treat individuals having a disease, disorder or condition
RU2006132068A (ru) * 2004-02-06 2008-03-20 Терадайм, Инк. (Us) Композиции и способы, относящиеся к культивированию нейрональных стволовых клеток со стромальными клетками костного мозга
WO2005085426A1 (ja) * 2004-03-04 2005-09-15 Tanabe Seiyaku Co., Ltd. 無フィ−ダ−分化用培地及び霊長類動物胚性幹細胞からの無フィ−ダ−分化方法
CA2504451A1 (en) * 2004-08-10 2006-02-10 Geron Corporation Dendritic cell vaccines for treating cancer made from embryonic stem cells
MX2007008437A (es) * 2005-01-11 2008-02-19 Cognate Therapeutics Inc Celulas estromales de medula osea para inmunoproteccion de celulas madre neurales transplantadas.
JP2006254872A (ja) * 2005-03-18 2006-09-28 Kenzaburo Tani 幹細胞分化の促進方法
CN101228264B (zh) 2005-06-22 2017-12-26 阿斯特利亚斯生物治疗股份公司 使灵长类多能干细胞分化成心肌细胞系细胞
AU2006286149B2 (en) 2005-08-29 2012-09-13 Technion Research And Development Foundation Ltd. Media for culturing stem cells
RS53210B (en) 2005-10-13 2014-08-29 Anthrogenesis Corporation IMMUNOMODULATION USING PLACENTA CELL CELLS
WO2007079183A2 (en) 2005-12-29 2007-07-12 Anthrogenesis Corporation Placental stem cell populations
ES2534332T3 (es) 2006-03-07 2015-04-21 Vaxinnate Corporation Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
CA2687446A1 (en) * 2006-05-17 2007-11-29 Cognate Therapeutics, Inc. Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates
DK2733203T3 (en) 2006-08-02 2019-02-04 Technion Res & Dev Foundation PROCEDURES FOR EXPANSION OF EMBRYONAL STEM CELLS IN A SUSPENSION CULTURE
RS52921B (en) 2007-02-12 2014-02-28 Anthrogenesis Corporation TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS
AU2008216748A1 (en) 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and CD34+, CD45- placental stem cell-enriched cell populations
WO2009120891A2 (en) 2008-03-27 2009-10-01 Geron Corporation Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
CA2965883C (en) 2008-08-22 2020-05-12 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
AU2010315712B2 (en) 2009-10-19 2014-04-17 FUJIFILM Cellular Dynamics, Inc. Cardiomyocyte production
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
AU2012236707B2 (en) 2011-03-29 2017-07-20 Asterias Biotherapeutics, Inc. Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells
CN113559126A (zh) 2011-06-01 2021-10-29 人类起源公司 利用胎盘干细胞治疗疼痛
EP4218779A1 (en) * 2013-05-22 2023-08-02 National Center Of Neurology And Psychiatry Stem cells for transplantation and manufacturing method therefor
BR112018008648A2 (pt) 2015-10-30 2018-11-27 Univ California métodos de geração de células t a partir de células tronco e métodos imunoterapêuticos ao usar células t
CN109439617A (zh) * 2018-12-25 2019-03-08 成都赋智健康科技有限公司 一种干细胞无血清培养基及其制作方法
CN111996164A (zh) * 2020-09-10 2020-11-27 聊城市人民医院 一种间充质干细胞的无血清抗衰老培养基
WO2023039588A1 (en) 2021-09-13 2023-03-16 FUJIFILM Cellular Dynamics, Inc. Methods for the production of committed cardiac progenitor cells
WO2024073776A1 (en) 2022-09-30 2024-04-04 FUJIFILM Cellular Dynamics, Inc. Methods for the production of cardiac fibroblasts

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) * 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5843425A (en) * 1992-02-19 1998-12-01 The General Hospital Corporation Transplantation and graft-versus-host-disease
US5672499A (en) * 1992-07-27 1997-09-30 California Institute Of Technology Immoralized neural crest stem cells and methods of making
US5589582A (en) * 1992-10-27 1996-12-31 Biotransplant, Inc. Polynucleotides en coding porcine cytokines
US5489304A (en) * 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5914268A (en) * 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5733541A (en) * 1995-04-21 1998-03-31 The Regent Of The University Of Michigan Hematopoietic cells: compositions and methods
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US6006752A (en) * 1996-05-09 1999-12-28 The General Hospital Corporation Mixed chimerism and tolerance
WO1998042838A1 (en) * 1997-03-25 1998-10-01 Morphogenesis, Inc. Universal stem cells
US6090622A (en) * 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
US5968829A (en) * 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
IL141699A0 (en) * 1998-09-01 2002-03-10 Wisconsin Alumni Res Found Primate embryonic stem cells with compatible histocompatibility genes
GB9824306D0 (en) * 1998-11-05 1998-12-30 Isis Innovation Method for producing dendritic dells
IL147990A0 (en) * 1999-08-05 2002-09-12 Mcl Llc Multipotent adult stem cells and methods for isolation
DE10061334A1 (de) * 2000-12-04 2002-06-13 Max Delbrueck Centrum Verwendung von aus embryonalen Stammzellen hergeleiteten Zellen zur Erhöhung der Transplantationstoleranz und zur Wiederherstellung zerstörten Gewebes

Also Published As

Publication number Publication date
CA2427996A1 (en) 2002-06-06
EP1335972A2 (en) 2003-08-20
JP2004521877A (ja) 2004-07-22
US20020086005A1 (en) 2002-07-04
EP1757681A1 (en) 2007-02-28
GB2386125A (en) 2003-09-10
WO2002044343A2 (en) 2002-06-06
AU2002239294B2 (en) 2006-05-11
AU2006203390A1 (en) 2006-08-31
US20060002906A1 (en) 2006-01-05
GB0313387D0 (en) 2003-07-16
WO2002044343A3 (en) 2003-01-16
GB2386125B (en) 2005-02-23
CN1863906A (zh) 2006-11-15
KR20040029311A (ko) 2004-04-06
AU3929402A (en) 2002-06-11

Similar Documents

Publication Publication Date Title
GB2386125B (en) Tolerizing allografts of pluripotent stem cells
GB2399823B (en) Islet cells from primate pluripotent stem cells
GB2392674B (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
GB2399572B (en) Hematopoietic cells from human embryonic stem cells
EP1562636A4 (en) MESENCHYMAL STEM CELLS AND METHODS OF USE
GB0400570D0 (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
GB2394958B (en) Methods of inducing differentiation of stem cells
GB0414558D0 (en) A method for the establishment of a pluripotent human blastocyst-derived stem cell line
HUP0301575A3 (en) Methods of modifying eukaryotic cells
IL156132A0 (en) Transfection of human embryonic stem cells
EP1325953A4 (en) METHOD FOR CULTIVATING MESENCHYMAL STEM CELLS
GB2375351B (en) Retrodifferentiation of cells to form undifferentiated cells
AU2002306865A1 (en) Generation of multipotent central nervous system stem cells
GB0026252D0 (en) Pluripotential stem cells
AU3350201A (en) Pancreatic islet cell growth factors
EP1445311A4 (en) METHOD FOR AMPLIFYING STEM HEMATOPOIETIC CELLS
AU9349701A (en) Manipulation of plant cell walls
GB0025088D0 (en) Stem cells
GB2359815B (en) Method of fastening external prostheses
AU2002239306A1 (en) Immunocompetent animals including xenogeneic implants of mesenchymal stem cells
GB2362453B (en) Gassing of containers
IL156841A0 (en) Pluripotent adult stem cells derived from regenerative tissue
AU2002241986A1 (en) Differentiation of stem cells to pancreatic endocrine cells
GB0026967D0 (en) Stem cell therapy
TW477221U (en) Structure of artificial hand